Get the Stockscreener App
25.20
0.00%
0.00
Shl Telemedicine Ltd Performanc stock is traded at $25.20, with a volume of 825.
It is up +0.00% in the last 24 hours and down -0.10% over the past month.
See More
Previous Close:
$25.20
Open:
$25.2099
24h Volume:
825
Relative Volume:
0.51
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.30%
1M Performance:
-0.10%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$25.20
$25.21
1-Week Range:
$25.17
$25.21
52-Week Range:
$25.13
$25.54
Shl Telemedicine Ltd Performanc Stock (STBF) Company Profile
Name
Shl Telemedicine Ltd Performanc
Sector
Industry
Phone
-
Address
-
Compare STBF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| STBF | 25.20 | 0 | 0 | 0 | 0 | 0.00 |
| VTI | 296.51 | 417.53B | 0 | 0 | 0 | 0.00 |
| SPY | 595.51 | 372.57B | 0 | 0 | 0 | 0.00 |
| IVV | 598.45 | 253.41B | 0 | 0 | 0 | 0.00 |
| VB | 257.73 | 160.59B | 0 | 0 | 0 | 0.00 |
| QQQ | 505.79 | 124.43B | 0 | 0 | 0 | 0.00 |
Shl Telemedicine Ltd Performanc Stock (STBF) Latest News
Y.D. More Investments Ltd Reduces Stake in SHL Telemedicine Ltd - GuruFocus.com
SHL Telemedicine stock hits 52-week low at $2.54 amid challenges By Investing.com - Investing.com South Africa
SHL Telemedicine stock hits 52-week low at $2.54 amid challenges - Investing.com
SHL Telemedicine stock hits 52-week low at $2.6 amid steep decline - Investing.com
Market Cool On SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 27% Lower - Simply Wall St
Shareholders in SHL Telemedicine (VTX:SHLTN) have lost 83%, as stock drops 11% this past week - Simply Wall St
2,219,610 Shares in SHL Telemedicine Ltd. (NASDAQ:SHLT) Purchased by Y.D. More Investments Ltd - MarketBeat
SHL Telemedicine stock hits 52-week low at $3.24 amid challenges - Investing.com India
Investors Give SHL Telemedicine Ltd. (VTX:SHLTN) Shares A 32% Hiding - Simply Wall St
SHL Telemedicine Stock Hits 52-Week Low at $3.7 Amid Challenges - Investing.com Australia
SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine - Business Wire
SHL Telemedicine Ltd. (VTX:SHLTN): Is Breakeven Near? - Simply Wall St
SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity - Business Wire
SHL Telemedicine Announces Official Launch of SmartHeart - Business Wire
SHL Announces Full-Year 2023 ResultsStable Revenue Growth Alongside Groundbreaking Clinical Milestones - Business Wire
Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care - Business Wire
SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment - Business Wire
SHL Telemedicine Introduces SmartHeart® Direct-to-Consumer Membership Plan in the US - Business Wire
SHL Telemedicine Announces Advancements in its Direct-to-Consumer Strategy in the US - Business Wire
SHL Announces Half-Year Results 2023 – Strategic Moves to Accelerate Growth - Business Wire
SHL Telemedicine to Commence Trading on NASDAQ Under the Symbol "SHLT" - PR Newswire
What Can We Make Of SHL Telemedicine Ltd.’s (VTX:SHLTN) High Return On Capital? - Yahoo Finance
Shl Telemedicine Ltd Performanc Stock (STBF) Financials Data
There is no financial data for Shl Telemedicine Ltd Performanc (STBF). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.73%
Cap:
|
Volume (24h):